Skin lesions ( Fig. 1 a) of an 8 year old boy with cobalamic C disease. The diagnosis of cobalamin C disease was confirmed by molecular studies (homozygous pathogenic mutation, c.567dupT in MMACHC gene) after newborn screen showed elevated C3. Treatment with betaine, hydroxocobalmin, and leucovorin was initiated soon after the diagnosis. However, the patient was poorly compliant. At presentation of these lesions, homocysteine was 181.2 μmol/l. Plasma methionine was very low and plasma methylmalonic acid was high (Suppl. Table 1 ). Patient was on unrestricted diet and his essential amino acid levels were normal (Suppl. Table 2 ). Home care nursing and school health services were involved to ensure compliance with treatment which consisted of vitamin B12 injections (10 mg/Kg/day intramuscular), betaine (250 mg/Kg in two divided doses), and folinic acid (2.5 mg three times a day). Within a week, lesions improved and healed by 6 weeks. Metabolic parameters showed improving trend with improvement in the lesions ( Fig. 1 b-d , Suppl. Table 1 ). Biopsy of a lesion (Fig. 1 e) showed acanthosis, spongiosis and perivascular lymphocytic and eosinophilic infiltrates (Fig. 1 f) . Cutaneous manifestation is rare in Cobalamin C disease. Two patients with cobalamin C defect presented with diffuse erythema and desquamation resembling acrodermatitis enteropathica (Howard et al 1997) . Such lesions have been described in many metabolic disorders (Tabanlioğlu et al 2009) . Nutritional deficiencies secondary to restricted diet is considered responsible. However, the patients reported by Howard et al did not have nutritional deficiencies and skin lesions resolved with treatment. Underlying metabolic disease rather than nutritional deficiencies was considered the etiology. However, detailed metabolic parameters were not provided.
Vitamin B12 deficiency has been associated with cutaneous lesions including atopic dermatitis and aphthous stomatitis (Brescoll and Daveluy 2015) . Vitamin B12 was shown to have an anti-inflammatory effect (Yamashiki et al 1992) . Hence, it appears that skin lesion in cobalamin C disease is directly related to underlying metabolic defect and not nutritional deficiencies. Appearance of skin lesions should lead to consideration of poor metabolic control due to noncompliance or inadequate doses. A timely diagnosis is essential as these lesions are reversible.
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